Is the DeSci track making a comeback? The new platform Pump.Science is about to launch.

Decentralized Science ( DeSci ) track has recently welcomed major news. The long-dormant established project Pump.Science announced that it will launch a new token launch platform next week. Upon the announcement, the prices of two tokens, $Rif and $Uro, immediately rose by 20%. Previously, the co-founder of Pump.Science had stated plans to launch 20 new compound tokens by Christmas 2024, but the actual launch time has been delayed.

In the past three months, affected by external factors, the market capitalization of Pump.Science's official tokens $Rif and $Uro has decreased by over 95% from their peaks. During the same period, the DeSci finance project BIO also dropped by about 90% after being listed on a certain platform. The once highly regarded DeSci track seems to have fallen into a trough.

Can the new platform Pump.Science revitalize DeSci?

According to the official documentation of the Pump.Science community, the operation process of the new platform is as follows:

• Users list compounds and tokens on the platform
• Users can buy and sell tokens through curves similar to Pump.fun, supporting this compound research.
• 79% of the tokens were issued through a curve, and the curve closed when the market value reached 303 Sol.
• 82 Sol liquidity will be transferred to Meteora trading
• 3 Sol used to pay for related experimental costs

It is worth noting that the new platform will implement a dynamic fee structure to deter sniping bots:

• The first 150 periods ( about 2 minutes ) the cost is extremely high ( 99.99% )
• 150-250 time slots ( 2-4 minutes ) costs drop rapidly
• Reduce front-running through dynamic fees

All new compounds must airdrop a certain share to $Rif and $Uro holders. Clearly, Pump.Science's move is an attempt at self-rescue. The weak DeSci track urgently needs new focal points and wealth creation effects. Currently, investors on the Sol chain are exhausted from AI tokens and celebrity coins, while new diversions are appearing on the BSC chain. Can DeSci spark a craze again? Can new compounds, new developers, and new attention activate more gameplay? The DeSci track seems to have reached a crucial moment that will determine its fate.

EGS Project Sparks Heated Discussion

On February 9, Pump.Science officially commented on the upcoming compound project $EGS: "Winning trust is the most commendable thing." $EGS began a 24-hour presale on February 7. On-chain data shows that a total of 1223 Sol was raised. Notably, the project party announced a refund of 91.87% of the funds raised, keeping only 100 Sol for launch and liquidity support. This "overfunding high refund" strategy is similar to the previously popular $pain project, but the refund ratio sets a precedent for DeSci projects. The project party stated: "Within 24 hours, with no marketing and no big holders, we proved our trust in science." They announced that EGS will open at a market cap of 100k to reward supporters, with presale participants earning about three times their investment.

EGS stands for Epigallocatechin Gallate and Glucosinolates. EGCG is the main active component of green tea, known as the "king of antioxidants", which can extend the lifespan of certain organisms by 20%. Glucosinolates are derived from vegetables like broccoli, which can extend the lifespan of mice by 15%. Both substances delay aging through multiple mechanisms and have clinical application potential.

Clearly, the new compound continues the monetization logic of IP from Rif and Uro by reducing risks through high refunds. This is the "low threshold, high return" story that DeSci urgently needs. However, whether such a topical presale method can replicate the success of Rif and Uro on the new platform remains unknown. Pump.Science co-founder admits: "DeSci faces the challenge of grand narratives but difficult implementation." Balancing support for science and speculative returns is key. In the current market environment, a purely decentralized scientific narrative is hard to gain recognition. The revival path of the DeSci track is still difficult and requires more eye-catching gameplay to gain attention. We hope that this new compound from Pump.Science can bring new increments to the sluggish DeSci track and also provide double returns, both wealth and spiritual, to the persistent supporters as promised.

Pump.Science New Compound Overview

1. Pomegranate polyphenols & Berberine: Antioxidant, anti-inflammatory, regulates blood sugar
2. Resveratrol & Berberine: Activate metabolic pathways, enhance cell repair
3. Ginsenoside Rh2: anti-cancer, neuroprotective, anti-inflammatory
4. Asparagus & Caffeine: Antioxidant, Blood Sugar Lowering, Energy Boosting
5. Cotton phenol & catechin hydrate: anticancer, metabolic regulation, antioxidant
6. Biotin & Berberine: Improve lipid metabolism and regulate blood sugar
7. Urolithin A & EGCG: Promotes mitochondrial regeneration, antioxidant
8. Berberine & Quercetin: Metabolic regulation, anti-inflammatory, antioxidant
9. Hesperidin & Dihydroquercetin: Improve blood circulation, protect the liver
10. EGCG: Powerful antioxidant, anti-inflammatory
11. Caffeine: Enhances cognitive function, boosts endurance
12. Artemisinin: anti-malarial, anti-cancer, anti-inflammatory

Recently, a research institution published a paper affirming the DeSci track, and BIO, Rif, and Uro subsequently rose by 20%. DeSci seems to be gaining attention again. These compounds are set to launch on the new Pump.Science platform, and investors need to continuously pay attention to quality projects and carefully choose teams that are serious about their work.